ORIFARM SUPPLY A/S: Financial statements 2017
CVR: 17153684
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
ORIFARM SUPPLY A/S (CVR 17153684) has filed annual accounts for 2017. In 2017, the company reported revenue of DKK 4,965,464,000 and a net result of DKK 86,200,000 compared with DKK 41,711,000 the year before. That is an increase of 6% compared with the year before. The profit margin was 1.7%. Equity in the 2017 report amounted to DKK 334,545,000. The solvency ratio was 32.8%. The company had 80 employees in the financial year.
- Revenue
- DKK 4,965,464,000
- Gross Profit
- DKK 180,569,000
- Profit/Loss
- DKK 86,200,000
- Equity
- DKK 334,545,000
- Total Assets
- DKK 1,020,999,000
- Employees
- 80
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | 5B | 180.6M | 86.2M | 334.5M | 80 |
| 2016 | 4.7B | 111.6M | 41.7M | 246.1M | 46 |
| 2015 | 5B | 133.8M | 13.3M | 203.2M | - |
| 2014 | 5.2B | 114.7M | 9.6M | 68.3M | - |
| 2013 | 3.4B | 87.3M | -24.4M | 58.8M | - |
Official annual report
Keep an eye on ORIFARM SUPPLY A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
ORIFARM SUPPLY A/S has published its annual report for 2016. Revenue came to DKK 4,685,833,000, and the net result was DKK 41,711,000.
About ORIFARM SUPPLY A/S
ORIFARM SUPPLY A/S is a Danish company of the type Aktieselskab based in Odense S, founded in 1993. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named MEDIPACK A/S and SBH2 ApS. The management consists of Mads Fink Eriksen. The board consists of Ole Michael Friis (chair), Birgitte Bøgh-Sørensen, Hans Carl Bøgh-Sørensen and Nicki Lund Kristensen. The company is owned by MEDIPACK HOLDING A/S. The company has 188 employees (2026). In 2025, the company reported revenue of DKK 11,714,817,000 and a net result of DKK 253,440,000 compared with DKK 269,398,000 the year before. Equity in the 2025 report amounted to DKK 1,337,548,000.